中文
Products

HIV-Ab & TP-Ab & HBsAg & HCV-Ab combo Self-Test kit

HIV-Ab & TP-Ab & HBsAg & HCV-Ab combo Self-Test kit (Colloidal Gold)

Intended Use

For the qualitative detection of HIV antibody (HIV-Ab), Treponema pallidum antibody (TP-Ab), HBV surface antigen (HBsAg) and HCV antibodies (HCV-Ab) in human capillary blood.

HIV-Ab & TP-Ab & HBsAg & HCV-Ab combo Self-Test kit

Clinical Department

Clinical Laboratory, Surgical Department, Transfusion Medicine Department, Infectious Diseases Department, Hepatology Department, Obstetrics and Gynaecology Department, Andrology Department, Emergency Department, ICU, Physical Examination Center, Dermatology Department, etc.

Product Parameters Clinical application

[Product Name]HIV-Ab & TP-Ab & HBsAg & HCV-Ab combo Self-Test kit

[Sample Type]capillary blood

[Intended Use]
For the qualitative detection of HIV antibody (HIV-Ab), Treponema pallidum antibody (TP-Ab), HBV surface antigen (HBsAg) and  HCV antibodies (HCV-Ab) in human capillary blood.

[Clinical Department]
Clinical Laboratory, Surgical Department, Transfusion Medicine Department, Infectious Diseases Department, Hepatology Department, Obstetrics and Gynaecology Department, Andrology Department, Emergency Department, ICU, Physical Examination Center, Dermatology Department, etc.


Product Parameters

Item

HIV-Ab & TP-Ab & HBsAg & HCV-Ab

Test Time

15-20min

Sample Type

capillary blood

Sensitivity

1.16 COI; 1.10 COI; 2.5 IU/mL; 1.05 COI

Storage Condition

4-30℃

Packing Specification

1 Test/Kit; 5 Tests/Kit; 10 Tests/Kit; 20 Tests/Kit; 40 Tests/Kit


1.Early screening for HIV infection, syphilis, hepatitis B and hepatitis C.

2.Assist in determining infection status, infectivity and the level of past exposure risk.

3.Used for differential screening of fever of unknown origin, abnormal liver function and suspected infectious diseases.

4.Support infection risk assessment prior to surgery, transfusion and invasive procedures, so as to reduce the risk of iatrogenic transmission.

5.Suitable for health screening and dynamic monitoring of physical examination populations and high-risk groups (e.g., high-exposure-risk groups, pregnant and postpartum populations, patients with chronic liver disease).


微信公众平台

官网二维码